Myeloid neoplasms with episodes suggestive of immunodeficiency/IBD and a marked reduction or absence of B cells, monocytes, NK cells, and dendritic cells should be actively screened for GATA2 variants. Here, GATA2 is linked to inflammatory bowel disease.